SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
Archives of pathology & laboratory medicine 2021 Jan 145 (1): 90-98.
Nambirajan Aruna, Singh Varsha, Bhardwaj Nishu, Mittal Saurabh, Kumar Sunil, Jain Deepa
Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.
BMC cancer 2016 16 (1): 28.
Samulin Erdem Johanna, Skaug Vidar, Bakke Per, Gulsvik Amund, Haugen Aage, Zienolddiny Shanb